Table of Content

1 Report Overview
1.1 Antiretroviral Therapy Definition
1.2 Market by Type
1.2.1 Global Antiretroviral Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 NNRTIs
1.2.3 NRTI
1.2.4 Multiclass Combination Products
1.2.5 Integrase Inhibitors
1.3 Market Segment by Application
1.3.1 Global Antiretroviral Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Antiretroviral Therapy Sales
2.1 Global Antiretroviral Therapy Revenue Estimates and Forecasts 2018-2034
2.2 Global Antiretroviral Therapy Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Antiretroviral Therapy Revenue by Region
2.3.1 Global Antiretroviral Therapy Revenue by Region (2018-2024)
2.3.2 Global Antiretroviral Therapy Revenue by Region (2024-2034)
2.4 Global Antiretroviral Therapy Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Antiretroviral Therapy Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Antiretroviral Therapy Sales Quantity by Region
2.6.1 Global Antiretroviral Therapy Sales Quantity by Region (2018-2024)
2.6.2 Global Antiretroviral Therapy Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Antiretroviral Therapy Sales Quantity by Manufacturers
3.1.1 Global Antiretroviral Therapy Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Antiretroviral Therapy Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Antiretroviral Therapy Sales in 2022
3.2 Global Antiretroviral Therapy Revenue by Manufacturers
3.2.1 Global Antiretroviral Therapy Revenue by Manufacturers (2018-2024)
3.2.2 Global Antiretroviral Therapy Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Antiretroviral Therapy Revenue in 2022
3.3 Global Antiretroviral Therapy Sales Price by Manufacturers
3.4 Global Key Players of Antiretroviral Therapy, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antiretroviral Therapy, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antiretroviral Therapy, Product Offered and Application
3.8 Global Key Manufacturers of Antiretroviral Therapy, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Antiretroviral Therapy Sales Quantity by Type
4.1.1 Global Antiretroviral Therapy Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Antiretroviral Therapy Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Antiretroviral Therapy Sales Quantity Market Share by Type (2018-2034)
4.2 Global Antiretroviral Therapy Revenue by Type
4.2.1 Global Antiretroviral Therapy Historical Revenue by Type (2018-2024)
4.2.2 Global Antiretroviral Therapy Forecasted Revenue by Type (2024-2034)
4.2.3 Global Antiretroviral Therapy Revenue Market Share by Type (2018-2034)
4.3 Global Antiretroviral Therapy Price by Type
4.3.1 Global Antiretroviral Therapy Price by Type (2018-2024)
4.3.2 Global Antiretroviral Therapy Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Antiretroviral Therapy Sales Quantity by Application
5.1.1 Global Antiretroviral Therapy Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Antiretroviral Therapy Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Antiretroviral Therapy Sales Quantity Market Share by Application (2018-2034)
5.2 Global Antiretroviral Therapy Revenue by Application
5.2.1 Global Antiretroviral Therapy Historical Revenue by Application (2018-2024)
5.2.2 Global Antiretroviral Therapy Forecasted Revenue by Application (2024-2034)
5.2.3 Global Antiretroviral Therapy Revenue Market Share by Application (2018-2034)
5.3 Global Antiretroviral Therapy Price by Application
5.3.1 Global Antiretroviral Therapy Price by Application (2018-2024)
5.3.2 Global Antiretroviral Therapy Price Forecast by Application (2024-2034)
6 North America
6.1 North America Antiretroviral Therapy Sales by Company
6.1.1 North America Antiretroviral Therapy Revenue by Company (2018-2024)
6.1.2 North America Antiretroviral Therapy Sales Quantity by Company (2018-2024)
6.2 North America Antiretroviral Therapy Market Size by Type
6.2.1 North America Antiretroviral Therapy Sales Quantity by Type (2018-2034)
6.2.2 North America Antiretroviral Therapy Revenue by Type (2018-2034)
6.3 North America Antiretroviral Therapy Market Size by Application
6.3.1 North America Antiretroviral Therapy Sales Quantity by Application (2018-2034)
6.3.2 North America Antiretroviral Therapy Revenue by Application (2018-2034)
6.4 North America Antiretroviral Therapy Market Size by Country
6.4.1 North America Antiretroviral Therapy Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Antiretroviral Therapy Revenue by Country (2018-2034)
6.4.3 North America Antiretroviral Therapy Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Antiretroviral Therapy Sales by Company
7.1.1 Europe Antiretroviral Therapy Sales Quantity by Company (2018-2024)
7.1.2 Europe Antiretroviral Therapy Revenue by Company (2018-2024)
7.2 Europe Antiretroviral Therapy Market Size by Type
7.2.1 Europe Antiretroviral Therapy Sales Quantity by Type (2018-2034)
7.2.2 Europe Antiretroviral Therapy Revenue by Type (2018-2034)
7.3 Europe Antiretroviral Therapy Market Size by Application
7.3.1 Europe Antiretroviral Therapy Sales Quantity by Application (2018-2034)
7.3.2 Europe Antiretroviral Therapy Revenue by Application (2018-2034)
7.4 Europe Antiretroviral Therapy Market Size by Country
7.4.1 Europe Antiretroviral Therapy Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Antiretroviral Therapy Revenue by Country (2018-2034)
7.4.3 Europe Antiretroviral Therapy Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Antiretroviral Therapy Sales by Company
8.1.1 China Antiretroviral Therapy Sales Quantity by Company (2018-2024)
8.1.2 China Antiretroviral Therapy Revenue by Company (2018-2024)
8.2 China Antiretroviral Therapy Market Size by Type
8.2.1 China Antiretroviral Therapy Sales Quantity by Type (2018-2034)
8.2.2 China Antiretroviral Therapy Revenue by Type (2018-2034)
8.3 China Antiretroviral Therapy Market Size by Application
8.3.1 China Antiretroviral Therapy Sales Quantity by Application (2018-2034)
8.3.2 China Antiretroviral Therapy Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Antiretroviral Therapy Sales by Company
9.1.1 APAC Antiretroviral Therapy Sales Quantity by Company (2018-2024)
9.1.2 APAC Antiretroviral Therapy Revenue by Company (2018-2024)
9.2 APAC Antiretroviral Therapy Market Size by Type
9.2.1 APAC Antiretroviral Therapy Sales Quantity by Type (2018-2034)
9.2.2 APAC Antiretroviral Therapy Revenue by Type (2018-2034)
9.3 APAC Antiretroviral Therapy Market Size by Application
9.3.1 APAC Antiretroviral Therapy Sales Quantity by Application (2018-2034)
9.3.2 APAC Antiretroviral Therapy Revenue by Application (2018-2034)
9.4 APAC Antiretroviral Therapy Market Size by Region
9.4.1 APAC Antiretroviral Therapy Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Antiretroviral Therapy Revenue by Region (2018-2034)
9.4.3 APAC Antiretroviral Therapy Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Antiretroviral Therapy Sales by Company
10.1.1 Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Antiretroviral Therapy Market Size by Type
10.2.1 Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Antiretroviral Therapy Market Size by Application
10.3.1 Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Antiretroviral Therapy Market Size by Country
10.4.1 Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Gilead
11.1.1 Gilead Company Information
11.1.2 Gilead Overview
11.1.3 Gilead Antiretroviral Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Gilead Antiretroviral Therapy Products and Services
11.1.5 Gilead Antiretroviral Therapy SWOT Analysis
11.1.6 Gilead Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Information
11.2.2 F. Hoffmann-La Roche Overview
11.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Products and Services
11.2.5 F. Hoffmann-La Roche Antiretroviral Therapy SWOT Analysis
11.2.6 F. Hoffmann-La Roche Recent Developments
11.3 ViiV Healthcare
11.3.1 ViiV Healthcare Company Information
11.3.2 ViiV Healthcare Overview
11.3.3 ViiV Healthcare Antiretroviral Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 ViiV Healthcare Antiretroviral Therapy Products and Services
11.3.5 ViiV Healthcare Antiretroviral Therapy SWOT Analysis
11.3.6 ViiV Healthcare Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Antiretroviral Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Boehringer Ingelheim Antiretroviral Therapy Products and Services
11.4.5 Boehringer Ingelheim Antiretroviral Therapy SWOT Analysis
11.4.6 Boehringer Ingelheim Recent Developments
11.5 Janssen Pharmaceuticals
11.5.1 Janssen Pharmaceuticals Company Information
11.5.2 Janssen Pharmaceuticals Overview
11.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Products and Services
11.5.5 Janssen Pharmaceuticals Antiretroviral Therapy SWOT Analysis
11.5.6 Janssen Pharmaceuticals Recent Developments
11.6 Mylan
11.6.1 Mylan Company Information
11.6.2 Mylan Overview
11.6.3 Mylan Antiretroviral Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Mylan Antiretroviral Therapy Products and Services
11.6.5 Mylan Antiretroviral Therapy SWOT Analysis
11.6.6 Mylan Recent Developments
11.7 Abbvie
11.7.1 Abbvie Company Information
11.7.2 Abbvie Overview
11.7.3 Abbvie Antiretroviral Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Abbvie Antiretroviral Therapy Products and Services
11.7.5 Abbvie Antiretroviral Therapy SWOT Analysis
11.7.6 Abbvie Recent Developments
11.8 Bionor Pharma
11.8.1 Bionor Pharma Company Information
11.8.2 Bionor Pharma Overview
11.8.3 Bionor Pharma Antiretroviral Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Bionor Pharma Antiretroviral Therapy Products and Services
11.8.5 Bionor Pharma Antiretroviral Therapy SWOT Analysis
11.8.6 Bionor Pharma Recent Developments
11.9 Vertex Pharmaceuticals
11.9.1 Vertex Pharmaceuticals Company Information
11.9.2 Vertex Pharmaceuticals Overview
11.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Products and Services
11.9.5 Vertex Pharmaceuticals Antiretroviral Therapy SWOT Analysis
11.9.6 Vertex Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Antiretroviral Therapy Value Chain Analysis
12.2 Antiretroviral Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antiretroviral Therapy Production Mode & Process
12.4 Antiretroviral Therapy Sales and Marketing
12.4.1 Antiretroviral Therapy Sales Channels
12.4.2 Antiretroviral Therapy Distributors
12.5 Antiretroviral Therapy Customers
13 Market Dynamics
13.1 Antiretroviral Therapy Industry Trends
13.2 Antiretroviral Therapy Market Drivers
13.3 Antiretroviral Therapy Market Challenges
13.4 Antiretroviral Therapy Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Antiretroviral Therapy Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of NNRTIs
Table 3. Major Manufacturers of NRTI
Table 4. Major Manufacturers of Multiclass Combination Products
Table 5. Major Manufacturers of Integrase Inhibitors
Table 6. Global Antiretroviral Therapy Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Antiretroviral Therapy Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Antiretroviral Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Antiretroviral Therapy Revenue Market Share by Region (2018-2024)
Table 10. Global Antiretroviral Therapy Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Antiretroviral Therapy Revenue Market Share by Region (2024-2034)
Table 12. Global Antiretroviral Therapy Sales Quantity by Region: 2018 VS 2022 VS 2034 (KG)
Table 13. Global Antiretroviral Therapy Sales by Region (2018-2024) & (KG)
Table 14. Global Antiretroviral Therapy Sales Market Share by Region (2018-2024)
Table 15. Global Antiretroviral Therapy Sales by Region (2024-2034) & (KG)
Table 16. Global Antiretroviral Therapy Sales Market Share by Region (2024-2034)
Table 17. Global Antiretroviral Therapy Sales Quantity by Manufacturers (2018-2024) & (KG)
Table 18. Global Antiretroviral Therapy Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Antiretroviral Therapy Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Antiretroviral Therapy Revenue Share by Manufacturers (2018-2024)
Table 21. Global Antiretroviral Therapy Price by Manufacturers 2018-2024 (USD/KG)
Table 22. Global Key Players of Antiretroviral Therapy, Industry Ranking, 2021 VS 2022
Table 23. Global Antiretroviral Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Antiretroviral Therapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiretroviral Therapy as of 2022)
Table 25. Global Key Manufacturers of Antiretroviral Therapy, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Antiretroviral Therapy, Product Offered and Application
Table 27. Global Key Manufacturers of Antiretroviral Therapy, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Antiretroviral Therapy Sales Quantity by Type (2018-2024) & (KG)
Table 30. Global Antiretroviral Therapy Sales Quantity by Type (2024-2034) & (KG)
Table 31. Global Antiretroviral Therapy Sales Quantity Share by Type (2018-2024)
Table 32. Global Antiretroviral Therapy Sales Quantity Share by Type (2024-2034)
Table 33. Global Antiretroviral Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Antiretroviral Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Antiretroviral Therapy Revenue Share by Type (2018-2024)
Table 36. Global Antiretroviral Therapy Revenue Share by Type (2024-2034)
Table 37. Antiretroviral Therapy Price by Type (2018-2024) & (USD/KG)
Table 38. Global Antiretroviral Therapy Price Forecast by Type (2024-2034) & (USD/KG)
Table 39. Global Antiretroviral Therapy Sales Quantity by Application (2018-2024) & (KG)
Table 40. Global Antiretroviral Therapy Sales Quantity by Application (2024-2034) & (KG)
Table 41. Global Antiretroviral Therapy Sales Quantity Share by Application (2018-2024)
Table 42. Global Antiretroviral Therapy Sales Quantity Share by Application (2024-2034)
Table 43. Global Antiretroviral Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Antiretroviral Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Antiretroviral Therapy Revenue Share by Application (2018-2024)
Table 46. Global Antiretroviral Therapy Revenue Share by Application (2024-2034)
Table 47. Antiretroviral Therapy Price by Application (2018-2024) & (USD/KG)
Table 48. Global Antiretroviral Therapy Price Forecast by Application (2024-2034) & (USD/KG)
Table 49. North America Antiretroviral Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Antiretroviral Therapy Sales Quantity by Company (2018-2024) & (KG)
Table 51. North America Antiretroviral Therapy Sales Quantity by Type (2018-2024) & (KG)
Table 52. North America Antiretroviral Therapy Sales Quantity by Type (2024-2034) & (KG)
Table 53. North America Antiretroviral Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Antiretroviral Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Antiretroviral Therapy Sales Quantity by Application (2018-2024) & (KG)
Table 56. North America Antiretroviral Therapy Sales Quantity by Application (2024-2034) & (KG)
Table 57. North America Antiretroviral Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Antiretroviral Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Antiretroviral Therapy Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Antiretroviral Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Antiretroviral Therapy Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Antiretroviral Therapy Sales Quantity by Country (2018-2024) & (KG)
Table 63. North America Antiretroviral Therapy Sales Quantity by Country (2024-2034) & (KG)
Table 64. Europe Antiretroviral Therapy Sales Quantity by Company (2018-2024) & (KG)
Table 65. Europe Antiretroviral Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Antiretroviral Therapy Sales Quantity by Type (2018-2024) & (KG)
Table 67. Europe Antiretroviral Therapy Sales Quantity by Type (2024-2034) & (KG)
Table 68. Europe Antiretroviral Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Antiretroviral Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Antiretroviral Therapy Sales Quantity by Application (2018-2024) & (KG)
Table 71. Europe Antiretroviral Therapy Sales Quantity by Application (2024-2034) & (KG)
Table 72. Europe Antiretroviral Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Antiretroviral Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Antiretroviral Therapy Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Antiretroviral Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Antiretroviral Therapy Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Antiretroviral Therapy Sales Quantity by Country (2018-2024) & (KG)
Table 78. Europe Antiretroviral Therapy Sales Quantity by Country (2024-2034) & (KG)
Table 79. China Antiretroviral Therapy Sales Quantity by Company (2018-2024) & (KG)
Table 80. China Antiretroviral Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Antiretroviral Therapy Sales Quantity by Type (2018-2024) & (KG)
Table 82. China Antiretroviral Therapy Sales Quantity by Type (2024-2034) & (KG)
Table 83. China Antiretroviral Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Antiretroviral Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Antiretroviral Therapy Sales Quantity by Application (2018-2024) & (KG)
Table 86. China Antiretroviral Therapy Sales Quantity by Application (2024-2034) & (KG)
Table 87. China Antiretroviral Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Antiretroviral Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Antiretroviral Therapy Sales Quantity by Company (2018-2024) & (KG)
Table 90. APAC Antiretroviral Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Antiretroviral Therapy Sales Quantity by Type (2018-2024) & (KG)
Table 92. APAC Antiretroviral Therapy Sales Quantity by Type (2024-2034) & (KG)
Table 93. APAC Antiretroviral Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Antiretroviral Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Antiretroviral Therapy Sales Quantity by Application (2018-2024) & (KG)
Table 96. APAC Antiretroviral Therapy Sales Quantity by Application (2024-2034) & (KG)
Table 97. APAC Antiretroviral Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Antiretroviral Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Antiretroviral Therapy Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Antiretroviral Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Antiretroviral Therapy Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Antiretroviral Therapy Sales Quantity by Region (2018-2024) & (KG)
Table 103. APAC Antiretroviral Therapy Sales Quantity by Region (2024-2034) & (KG)
Table 104. Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity by Company (2018-2024) & (KG)
Table 105. Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity by Type (2018-2024) & (KG)
Table 107. Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity by Type (2024-2034) & (KG)
Table 108. Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity by Application (2018-2024) & (KG)
Table 111. Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity by Application (2024-2034) & (KG)
Table 112. Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity by Country (2018-2024) & (KG)
Table 118. Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity by Country (2024-2034) & (KG)
Table 119. Gilead Company Information
Table 120. Gilead Description and Overview
Table 121. Gilead Antiretroviral Therapy Sales Quantity (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2018-2024)
Table 122. Gilead Antiretroviral Therapy Product and Services
Table 123. Gilead Antiretroviral Therapy SWOT Analysis
Table 124. Gilead Recent Developments
Table 125. F. Hoffmann-La Roche Company Information
Table 126. F. Hoffmann-La Roche Description and Overview
Table 127. F. Hoffmann-La Roche Antiretroviral Therapy Sales Quantity (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2018-2024)
Table 128. F. Hoffmann-La Roche Antiretroviral Therapy Product and Services
Table 129. F. Hoffmann-La Roche Antiretroviral Therapy SWOT Analysis
Table 130. F. Hoffmann-La Roche Recent Developments
Table 131. ViiV Healthcare Company Information
Table 132. ViiV Healthcare Description and Overview
Table 133. ViiV Healthcare Antiretroviral Therapy Sales Quantity (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2018-2024)
Table 134. ViiV Healthcare Antiretroviral Therapy Product and Services
Table 135. ViiV Healthcare Antiretroviral Therapy SWOT Analysis
Table 136. ViiV Healthcare Recent Developments
Table 137. Boehringer Ingelheim Company Information
Table 138. Boehringer Ingelheim Description and Overview
Table 139. Boehringer Ingelheim Antiretroviral Therapy Sales Quantity (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2018-2024)
Table 140. Boehringer Ingelheim Antiretroviral Therapy Product and Services
Table 141. Boehringer Ingelheim Antiretroviral Therapy SWOT Analysis
Table 142. Boehringer Ingelheim Recent Developments
Table 143. Janssen Pharmaceuticals Company Information
Table 144. Janssen Pharmaceuticals Description and Overview
Table 145. Janssen Pharmaceuticals Antiretroviral Therapy Sales Quantity (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2018-2024)
Table 146. Janssen Pharmaceuticals Antiretroviral Therapy Product and Services
Table 147. Janssen Pharmaceuticals Antiretroviral Therapy SWOT Analysis
Table 148. Janssen Pharmaceuticals Recent Developments
Table 149. Mylan Company Information
Table 150. Mylan Description and Overview
Table 151. Mylan Antiretroviral Therapy Sales Quantity (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2018-2024)
Table 152. Mylan Antiretroviral Therapy Product and Services
Table 153. Mylan Antiretroviral Therapy SWOT Analysis
Table 154. Mylan Recent Developments
Table 155. Abbvie Company Information
Table 156. Abbvie Description and Overview
Table 157. Abbvie Antiretroviral Therapy Sales Quantity (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2018-2024)
Table 158. Abbvie Antiretroviral Therapy Product and Services
Table 159. Abbvie Antiretroviral Therapy SWOT Analysis
Table 160. Abbvie Recent Developments
Table 161. Bionor Pharma Company Information
Table 162. Bionor Pharma Description and Overview
Table 163. Bionor Pharma Antiretroviral Therapy Sales Quantity (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2018-2024)
Table 164. Bionor Pharma Antiretroviral Therapy Product and Services
Table 165. Bionor Pharma Antiretroviral Therapy SWOT Analysis
Table 166. Bionor Pharma Recent Developments
Table 167. Vertex Pharmaceuticals Company Information
Table 168. Vertex Pharmaceuticals Description and Overview
Table 169. Vertex Pharmaceuticals Antiretroviral Therapy Sales Quantity (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2018-2024)
Table 170. Vertex Pharmaceuticals Antiretroviral Therapy Product and Services
Table 171. Vertex Pharmaceuticals Antiretroviral Therapy SWOT Analysis
Table 172. Vertex Pharmaceuticals Recent Developments
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. Antiretroviral Therapy Distributors List
Table 176. Antiretroviral Therapy Customers List
Table 177. Antiretroviral Therapy Market Trends
Table 178. Antiretroviral Therapy Market Drivers
Table 179. Antiretroviral Therapy Market Challenges
Table 180. Antiretroviral Therapy Market Restraints
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiretroviral Therapy Product Picture
Figure 2. Global Antiretroviral Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Antiretroviral Therapy Market Share by Type in 2022 & 2034
Figure 4. NNRTIs Product Picture
Figure 5. NRTI Product Picture
Figure 6. Multiclass Combination Products Product Picture
Figure 7. Integrase Inhibitors Product Picture
Figure 8. Global Antiretroviral Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Antiretroviral Therapy Market Share by Application in 2022 & 2034
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Antiretroviral Therapy Report Years Considered
Figure 14. Global Antiretroviral Therapy Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Antiretroviral Therapy Revenue 2018-2034 (US$ Million)
Figure 16. Global Antiretroviral Therapy Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 17. Global Antiretroviral Therapy Sales Quantity 2018-2034 (KG)
Figure 18. Global Antiretroviral Therapy Sales Quantity Market Share by Region (2018-2024)
Figure 19. Global Antiretroviral Therapy Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Antiretroviral Therapy Sales Quantity YoY (2018-2034) & (KG)
Figure 21. North America Antiretroviral Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Antiretroviral Therapy Sales Quantity YoY (2018-2034) & (KG)
Figure 23. Europe Antiretroviral Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Antiretroviral Therapy Sales Quantity YoY (2018-2034) & (KG)
Figure 25. China Antiretroviral Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Antiretroviral Therapy Sales Quantity YoY (2018-2034) & (KG)
Figure 27. APAC Antiretroviral Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity YoY (2018-2034) & (KG)
Figure 29. Middle East, Africa and Latin America Antiretroviral Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Antiretroviral Therapy Sales Quantity in 2022
Figure 31. The Top 10 and Top 5 Players Market Share by Antiretroviral Therapy Revenue in 2022
Figure 32. Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Antiretroviral Therapy Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Antiretroviral Therapy Revenue Market Share by Type (2018-2034)
Figure 35. Global Antiretroviral Therapy Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Antiretroviral Therapy Revenue Market Share by Application (2018-2034)
Figure 37. North America Antiretroviral Therapy Revenue Market Share by Company in 2022
Figure 38. North America Antiretroviral Therapy Sales Quantity Market Share by Company in 2022
Figure 39. North America Antiretroviral Therapy Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Antiretroviral Therapy Revenue Market Share by Type (2018-2034)
Figure 41. North America Antiretroviral Therapy Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Antiretroviral Therapy Revenue Market Share by Application (2018-2034)
Figure 43. North America Antiretroviral Therapy Revenue Share by Country (2018-2034)
Figure 44. North America Antiretroviral Therapy Sales Quantity Share by Country (2018-2034)
Figure 45. U.S. Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Antiretroviral Therapy Sales Quantity Market Share by Company in 2022
Figure 48. Europe Antiretroviral Therapy Revenue Market Share by Company in 2022
Figure 49. Europe Antiretroviral Therapy Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Antiretroviral Therapy Revenue Market Share by Type (2018-2034)
Figure 51. Europe Antiretroviral Therapy Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Antiretroviral Therapy Revenue Market Share by Application (2018-2034)
Figure 53. Europe Antiretroviral Therapy Revenue Share by Country (2018-2034)
Figure 54. Europe Antiretroviral Therapy Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 56. France Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 60. China Antiretroviral Therapy Sales Quantity Market Share by Company in 2022
Figure 61. China Antiretroviral Therapy Revenue Market Share by Company in 2022
Figure 62. China Antiretroviral Therapy Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Antiretroviral Therapy Revenue Market Share by Type (2018-2034)
Figure 64. China Antiretroviral Therapy Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Antiretroviral Therapy Revenue Market Share by Application (2018-2034)
Figure 66. APAC Antiretroviral Therapy Sales Quantity Market Share by Company in 2022
Figure 67. APAC Antiretroviral Therapy Revenue Market Share by Company in 2022
Figure 68. APAC Antiretroviral Therapy Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Antiretroviral Therapy Revenue Market Share by Type (2018-2034)
Figure 70. APAC Antiretroviral Therapy Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Antiretroviral Therapy Revenue Market Share by Application (2018-2034)
Figure 72. APAC Antiretroviral Therapy Revenue Share by Region (2018-2034)
Figure 73. APAC Antiretroviral Therapy Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 78. India Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Antiretroviral Therapy Revenue Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Antiretroviral Therapy Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Antiretroviral Therapy Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Antiretroviral Therapy Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Antiretroviral Therapy Revenue Share by Country (2018-2034)
Figure 87. Brazil Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Antiretroviral Therapy Revenue (2018-2034) & (US$ Million)
Figure 92. Antiretroviral Therapy Value Chain
Figure 93. Antiretroviral Therapy Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed